UV Flu Technologies, Inc. (UVFT) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
UV Flu Technologies, Inc. (UVFT) trades at $0.0002 with AI Score 58/100 (Grade B). UV Flu Technologies, Inc. specializes in air purification systems, utilizing UV technology to eliminate harmful microbes. Sector: Industrials.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for UVFT: UVFT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates UVFT against Industrials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
UVFT: the 3 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
UV Flu Technologies, Inc. (UVFT) Industrial Operations Profile
UV Flu Technologies, Inc. develops and sells air purification systems, including the ViraTech UV-400, which uses UV radiation to destroy harmful microbes. Targeting sectors like hospitality and healthcare, the company differentiates itself through advanced disinfection technology beyond traditional filtration.
What Is the Investment Thesis for UVFT?
UV Flu Technologies operates in the pollution and treatment controls industry, with a focus on air purification. The company's gross margin stands at 25.4%. With a market capitalization of $0.00B and negative free cash flow of $-0.00B, the company's financial position requires careful consideration. A key value driver is the increasing demand for air purification technologies, driven by growing awareness of airborne pathogens and indoor air quality. Upcoming catalysts include potential partnerships with larger HVAC companies and expansion into new markets. Potential risks include competition from established players and the need for continuous innovation to maintain a competitive edge.
Based on FMP financials and quantitative analysis
UVFT Key Highlights
Gross Margin of 25.4% reflects the company's profitability on sales after accounting for the cost of goods sold.
- Market Cap of $0.00B indicates the company's small size and potential for growth or volatility.
- Negative Free Cash Flow of $-0.00B suggests the company is currently spending more cash than it is generating.
- Beta of -65.43 indicates an inverse correlation to the market, though the magnitude raises questions about its reliability.
- Focus on UV-C technology provides a differentiated approach to air purification, targeting microbe destruction rather than just filtration.
Who Are UVFT's Competitors?
What Are UVFT's Key Strengths?
Proprietary UV-C technology for microbe destruction.
- Targeted solutions for specific industries.
- Established presence in niche markets.
- Focus on air purification beyond traditional filtration.
What Are UVFT's Weaknesses?
Small market capitalization.
- Negative free cash flow.
- Limited brand awareness.
- Dependence on a small number of products.
What Could Drive UVFT Stock Higher?
Potential partnerships with HVAC companies to integrate UV-C technology into existing systems.
- Expansion into new geographic markets, particularly in regions with high air pollution levels.
- Increasing awareness of airborne pathogens and the importance of indoor air quality.
- Development of new products and applications for UV-C air purification technology.
What Are the Key Risks for UVFT?
Financial-distress signal — its Altman Z-Score of -49.15 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Competition from larger, more established companies with greater resources.
- Technological advancements that could render existing UV-C technology obsolete.
- Changes in regulations and standards related to air purification.
- Economic downturn that could reduce demand for air purification systems.
- The company's small size and limited financial resources may hinder its ability to compete effectively.
What Are the Growth Opportunities for UVFT?
- Expansion into Healthcare Facilities: The healthcare sector represents a significant growth opportunity for UV Flu Technologies. Hospitals, clinics, and other medical facilities require stringent air purification to minimize the spread of infections. The company's ViraTech UV-400 is well-suited for these environments, offering advanced disinfection capabilities. Securing contracts with major hospital networks could substantially increase revenue. The global hospital-acquired infection control market is projected to reach $20 billion by 2028, providing a substantial addressable market.
- Partnerships with HVAC Companies: Collaborating with established HVAC (Heating, Ventilation, and Air Conditioning) companies can provide UV Flu Technologies with access to a broader customer base and distribution network. Integrating their UV-C technology into existing HVAC systems can enhance the air purification capabilities of these systems and create a competitive advantage. Strategic partnerships can accelerate market penetration and increase brand awareness. The HVAC market is expected to grow to over $300 billion by 2027.
- Development of Consumer Products: Expanding into the consumer market with smaller, more affordable UV air purifiers can unlock a new revenue stream for UV Flu Technologies. Targeting households concerned about indoor air quality, especially those with allergies or respiratory issues, can drive sales. This requires adapting the technology for consumer use and establishing a strong online presence.
- Geographic Expansion: While currently focused on the United States, UV Flu Technologies can expand its reach into international markets. Countries with high levels of air pollution, such as China and India, represent significant opportunities. Adapting products to meet local regulations and establishing distribution channels in these regions are crucial for success. The Asia-Pacific air purifier market is expected to be the fastest-growing region in the coming years.
- Customized Solutions for Specific Industries: Offering customized air purification solutions tailored to the specific needs of different industries can provide a competitive advantage. For example, developing specialized systems for food processing plants, pharmaceutical manufacturing facilities, or cleanrooms can address unique air quality challenges. This requires close collaboration with clients to understand their requirements and develop tailored solutions. The market for customized air purification systems is growing as industries seek to meet increasingly stringent air quality standards.
What Are UVFT's Competitive Advantages?
- Proprietary UV-C technology in the ViraTech UV-400 provides a differentiated approach to air purification.
- Focus on microbe destruction rather than just filtration.
- Targeted solutions for specific industries and applications.
- Established presence in niche markets like salons and kennels.
What Does UVFT Do?
UV Flu Technologies, Inc., founded in 2006 and based in Lincolnshire, Illinois, researches, develops, manufactures, and sells air purification systems and products, primarily in the United States. Originally known as Northwest Chariots Incorporated, the company rebranded in November 2009 to reflect its focus on UV-based air purification technology. Their flagship product, the ViraTech UV-400, employs high-intensity germicidal ultraviolet radiation within a specialized chamber to trap and destroy harmful microbes, going beyond simple filtration. In addition to the ViraTech UV-400, UV Flu Technologies offers the RX Air product line, which includes HEPA-based air purifiers. These products are designed for use in a variety of settings, including hotels, hair and nail salons, pet kennels, test labs, hospitals, restaurants, casinos, and military installations, addressing the need for improved air quality and disinfection in diverse environments. The company aims to provide solutions that enhance air safety and reduce the spread of airborne pathogens.
What Products and Services Does UVFT Offer?
- Researches and develops air purification systems.
- Manufactures air purification products.
- Sells air purification systems primarily in the United States.
- Offers the ViraTech UV-400, which uses UV radiation to destroy microbes.
- Provides RX Air product line, including HEPA-based air purifiers.
- Targets commercial and institutional customers.
- Aims to improve indoor air quality and reduce airborne pathogens.
How Does UVFT Make Money?
- Direct sales of air purification systems to businesses and institutions.
- Revenue from the sale of ViraTech UV-400 and RX Air products.
- Potential for recurring revenue through filter replacements and maintenance services.
- Customized solutions for specific industry needs.
What Industry Does UVFT Operate In?
UV Flu Technologies operates within the pollution and treatment controls industry, which is experiencing growth due to increasing awareness of air quality and health concerns. The market includes established players offering traditional filtration systems and emerging companies focusing on advanced technologies like UV-C disinfection. UV Flu Technologies differentiates itself with its ViraTech UV-400, which uses UV radiation to destroy microbes. The competitive landscape includes companies like Donaldson Co. and Clarcor, which offer a range of filtration solutions.
Who Are UVFT's Key Customers?
- Hotels seeking to improve air quality for guests.
- Hair and nail salons requiring air purification to reduce chemical odors and particles.
- Pet kennels aiming to control odors and airborne allergens.
- Test labs and hospitals needing sterile environments.
- Restaurants and casinos wanting to improve air quality for patrons.
- Military installations requiring air purification for personnel.
Financial Health
UV Flu Technologies, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -49.15 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for UV Flu Technologies, Inc. stands at 137.8%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.16 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
UV Flu Technologies, Inc. operates in the Industrial - Pollution & Treatment Controls industry within the Industrials sector. It is headquartered in Lincolnshire, US. The company is led by CEO Michael S. Ross. UVFT has traded publicly since 2009.
UVFT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in UVFT's growth potential, indicating management's belief in the company's future.
- Community sentiment has shifted positively as discussions around UVFT's innovative UV light technology gain traction.
- The increasing demand for sanitation solutions post-pandemic positions UVFT favorably in a growing market.
- Recent partnerships and collaborations hint at strategic moves that could enhance market reach and brand visibility.
Bear Case
- Concerns over the company's financial sustainability persist, as some investors remain skeptical about long-term profitability.
- Recent bearish sentiment in online discussions highlights worries about competition in the sanitation technology sector.
- The company's reliance on a niche market could limit growth opportunities, making it vulnerable to market fluctuations.
- Market perception has been mixed, with some analysts questioning the scalability of UVFT's current business model.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
UVFT Latest News
No recent news available for UVFT.
UVFT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for UVFT.
Price Targets
Wall Street price target analysis for UVFT.
UVFT MoonshotScore
What does this score mean?
The MoonshotScore rates UVFT 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Classification
Industry Pollution & Treatment ControlsUVFT OTC Market Information
UVFT trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
UV Flu Technologies, Inc. Industrials Stock: Key Questions Answered
What does the AI Score mean for UVFT?
UVFT holds an AI Score of 58/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. UV Flu Technologies, Inc. specializes in air purification systems, utilizing UV technology to eliminate harmful microbes. Their ViraTech UV-400 and RX Air product lines cater to various commercial …
What does UV Flu Technologies, Inc. do?
UV Flu Technologies, Inc. specializes in the development, manufacturing, and sale of air purification systems, primarily in the United States. Their core product, the ViraTech UV-400, utilizes high-intensity germicidal ultraviolet radiation to eliminate harmful microbes, offering a more advanced solution than traditional filtration methods. They also offer the RX Air product line, which includes HEPA-based air purifiers.
What are the main risks for UVFT?
UV Flu Technologies faces several risks inherent to its industry and size. Competition from larger, more established companies with greater financial and marketing resources poses a significant challenge. Technological advancements in air purification could render their existing UV-C technology obsolete. Changes in regulations and standards related to air quality could require costly adaptations.
What are the key factors to evaluate for UVFT?
UV Flu Technologies, Inc. (UVFT) holds an AI score of 58/100 (moderate). UV Flu Technologies operates in the pollution and treatment controls industry, with a focus on air purification. Not financial advice.
How frequently does UVFT data refresh on this page?
UVFT's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven UVFT's recent stock price performance?
UV Flu Technologies, Inc. (UVFT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary UV-C technology for microbe destruction. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider UVFT overvalued or undervalued right now?
UV Flu Technologies, Inc. (UVFT) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research UVFT before investing?
Before investing in UV Flu Technologies, Inc. (UVFT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding UVFT to a portfolio?
Key strength of UV Flu Technologies, Inc. (UVFT): Proprietary UV-C technology for microbe destruction. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- AI analysis pending.
- Small market capitalization increases volatility.